Smart Equity Invest

← Results dashboard

Q2 FY27 · NSE: COSMOFIRST

COSMO FIRST

Results filed 3 November 2026 · Market cap ₹2,183 crore · PE 9.8

GrowthGuidance maintainedTranscript read

Revenue
+51.0%
on a year ago
EBITDA
+39.3%
on a year ago
Profit to shareholders
+111.1%
on a year ago
EBITDA margin
10.3%
−1.3 pts on last quarter

Cosmo First delivered strong revenue growth of 51% YoY to Rs 1,388 crore in Q2 FY27, supported by 15% overall volume growth, improved BOPP spreads, and fast-growing B2B specialty verticals. While reported PAT jumped 111% YoY to Rs 98.6 crore, earnings were significantly boosted by non-recurring items including a Rs 24.8 crore US customs duty refund write-back and a Rs 14 crore tax transition credit. With the major Rs 1,250+ crore multi-year capex cycle completed, management's primary focus has shifted to deleveraging, reducing net debt to Rs 1,057 crore with a target to cut another Rs 300-500 crore over the next two years.

COSMO FIRST LIMITED, Q2 FY27₹ crore, consolidated
Q2 FY27Q1 FY27vs previous quarterQ2 FY26vs a year ago
Revenue1,3881,166+19.1%919+51.0%
Operating profit (EBIT)10598.05+6.8%68.6+52.6%
Operating margin7.5%8.4%−87 bps7.5%+8 bps
Other income33.6511.04+204.8%25.38+32.6%
Exceptional items−0.150–0–
Profit before exceptional items and tax98.3470.73+39.0%57.31+71.6%
Profit to shareholders98.5853.75+83.4%46.69+111.1%
Earnings per share (₹)37.9820.71+83.4%18.07+110.2%

Source: COSMO FIRST LIMITED’s filing to NSE, 3 November 2026. Operating profit is revenue less every expense except interest, so it leaves out other income and exceptional items. n.m.: not meaningful, because the earlier figure was zero or negative, or the latest one is a loss.

What stood out

  • Net profit growth (+111% YoY) significantly outpaced EBITDA growth (+38% YoY), primarily boosted by exceptional one-off items and adoption of a new tax regime.
    SourceQ2 FY27 EBITDA included Rs 24.8 crore duty refund write-back from US customs and Rs 7 crore inventory loss (net +Rs 18 crore impact); Q2 tax included a one-time credit of Rs 14 crore from shifting to the concessional tax regime, resulting in an expected negative effective tax rate of -6% to -7% for FY27 (Transcript, Page 5; Presentation, Slide 10).
  • Significant deleveraging achieved with net debt declining by over Rs 100 crore in H1 FY27 despite higher working capital requirements.
    SourceNet debt reduced to Rs 1,057 crore (1.9x EBITDA) as of September 2026 from Rs 1,159 crore (2.4x EBITDA) in March 2026, despite a working capital increase of Rs 148 crore due to raw material price inflation (Transcript, Page 6; Presentation, Slide 13).
  • Rigid packaging (Cosmo Plastech) posted its second consecutive profitable quarter with rapid scale-up.
    SourceCosmo Plastech Q2 revenue surged 90% YoY to Rs 39 crore with an 8% EBITDA margin, and direct-to-brand sales reached 67% (Transcript, Page 5; Presentation, Slide 27).

Guidance

MetricGuidancePeriod
Net Debt Reduction
SourceTranscript, Page 7
Reduce net debt by approximately Rs 300 to 500 crore over the next two years.Next 2 years (by FY29)
Capex
SourceTranscript, Page 8
FY27 full-year capex of Rs 100 to 110 crore; FY28 capex indicative range of Rs 50 to 70 crore.FY27 & FY28
Specialty Volume Share
SourceTranscript, Page 7
Around 60% in FY27, increasing to 65%-70% in FY28, and targeting ~80% in the medium term.FY27 - FY29
US Film Business Revenue
SourceTranscript, Page 7
Approximately $70 million in FY27 and exceeding $100 million in FY28.FY27 & FY28
Effective Tax Rate
SourceTranscript, Page 5
Tax income/credit range of -6% to -7% (tax writeback) for FY27 due to adoption of new concessional tax regime.FY27
Power Cost Savings
SourceTranscript, Page 4
Annual savings of Rs 25 to 30 crore from renewable energy accounting for ~two-thirds of power needs.Next year onwards
Cosmo Specialty Chemicals Revenue
SourceTranscript, Page 3; Presentation, Slide 25
Targeting Rs 500 crore revenue with 20%+ ROCE.Medium term / FY30
Cosmo Plastech Revenue
SourcePresentation, Slide 27
Targeting Rs 350 to 400 crore with double-digit EBITDA and ROCE.FY30
Cosmo Consumer & Zigly Growth
SourceTranscript, Page 9
Projecting more than 60% growth going forward in both consumer businesses.Near term

Tailwinds

  • Strong volume expansion and specialty mix improvement across core flexible packaging lines.
    SourceOverall volumes grew 15% YoY and specialty volumes rose 20% YoY, driving flexible packaging EBITDA up 33% YoY to Rs 171 crore (Transcript, Pages 4-5; Presentation, Slide 10).
  • Significant turnaround in base BOPP margins and BOPET margin improvement.
    SourceBOPP gross margins improved to Rs 29/kg in Q2 FY27 from Rs 22/kg in Q2 FY26 (up Rs 7/kg YoY); BOPET gross margin doubled to Rs 12/kg from Rs 6/kg YoY (Transcript, Page 5; Presentation, Slide 17).
  • Rapid scaling and profitability in non-film B2B businesses (Specialty Chemicals and Plastech).
    SourceSpecialty Chemicals revenue surged 84% YoY with 23% EBITDA margin; Plastech sales grew 90% YoY with 8% EBITDA margin, contributing incremental Rs 12 crore EBITDA combined (Transcript, Pages 4-5; Presentation, Slide 2).
  • Strong volume rebound in the USA film business following duty adjustments.
    SourceUS operations delivered >50% YoY revenue growth and 35% volume growth, tracking towards ~$70 million revenue in FY27 and >$100 million in FY28 (Transcript, Pages 4, 7, 14).

Headwinds

  • Continued EBITDA drag from early-stage consumer businesses (Zigly and Cosmo Consumer).
    SourceZigly Petcare posted an EBITDA loss of Rs 14 crore in Q2 FY27 (vs Rs 10 crore loss in Q2 FY26), and Cosmo Consumer recorded an EBITDA loss of Rs 4 crore due to TVC campaigns (Presentation, Slide 12; Transcript, Page 6).
  • Volatile raw material costs causing quarterly inventory losses.
    SourceA sharp decline in raw material prices during the quarter resulted in a Rs 7 crore inventory loss (Transcript, Page 5; Presentation, Slide 10).
  • Persistent logistics friction and port congestion linked to Middle East geopolitical issues.
    SourcePort-related challenges re-emerged during the quarter, creating ongoing operational uncertainty for exports (Transcript, Page 12).

New businesses and products

capacity expansion · Under installation / commissioning in H2 FY27

High-end chemical coated film line capacity expansion

Expected benefit
Addition of 16,000 MT annual capacity; provides high specialty margins with value-addition of US$0.70 to US$1.00 per kg (including base film margin).
Risks
Ramp-up takes 2-3 years as customer approvals in specialty markets take time.
Timeline
Commissioning in H2 FY27; full utilization over 2-3 years.
Investment
Largely incurred and included in Q2 FY27 financials.
SourceTranscript, Pages 3, 11, 12, 13; Presentation, Slide 11, 15

capacity expansion · Commissioning scheduled for H2 FY27

9-layer barrier sheet line for Cosmo Plastech (Rigid Packaging)

Expected benefit
Addition of 10,000 MT annual capacity; delivers high specialty margins with estimated value addition of ~US$0.70 per kg over base sheet; only one other competitor in India.
Risks
Customer approvals take time.
Timeline
H2 FY27
Investment
Minimal capex; already largely capitalized in Q2 FY27 financials.
SourceTranscript, Pages 3, 5, 9, 12, 13; Presentation, Slide 27

partnership · Joint venture established; customer approvals underway

South Korea Joint Venture with Filmax & Japan expansion

Expected benefit
Cross-distribution of specialty films (Cosmo products into Korea/Japan and their products into US/Europe) with higher realization and margins.
Risks
Lengthened customer approval cycles of 3 to 5 years in Korea and Japan.
Timeline
Phased ramp-up over 3 to 5 years.
SourceTranscript, Pages 12-13; Presentation, Slide 20

new business · Launched in FY26, nationwide rollout and TV advertising underway since July 2026

Cosmo Consumer (Sunshield Window Films and PPF)

Expected benefit
Targets Rs 200 crore revenue by FY30; tapping into a Rs 500 crore Indian PPF market growing at 30% YoY.
Risks
Continued operating losses due to high advertising and brand-building investments over the next 2 years.
Timeline
Brand-building phase for next 2 years; FY30 target Rs 200 crore.
Investment
Operating EBITDA loss of Rs 4-4.5 crore in Q2 FY27 due to TVC campaigns.
SourceTranscript, Pages 5, 10-11; Presentation, Slides 29-31

acquisition · Completed in September 2026

Acquisition of Prolife Specialty Vet Clinic (Mumbai) by Zigly

Expected benefit
Expands veterinary care footprint to 3 hospitals within a 48-center network; strengthens high-margin service revenue mix.
Risks
Near-term drag on parent EBITDA (Zigly reported EBITDA loss of Rs 14 crore in Q2).
Timeline
Completed in Sep-26
SourcePresentation, Slides 12, 31

Things to check

  • Profit grew far faster than operating profit: other income, tax or one-offs did some of the work
  • Reported PAT was heavily inflated by a one-off tax credit and non-recurring duty write-backs.
    SourceQ2 tax included a one-time credit of Rs 14 crore from shifting to the new concessional tax regime (projecting a negative tax rate of -6% to -7% for FY27), and EBITDA benefited from a Rs 24.8 crore customs duty write-back in the US subsidiary (Transcript, Page 5).
  • Widening losses in the B2C vertical Zigly Petcare.
    SourceZigly's EBITDA loss expanded from Rs 10 crore in Q2 FY26 to Rs 14 crore in Q2 FY27 despite a 47% growth in top-line (Presentation, Slide 12).

How the call went

High-quality call featuring participation from the Chairman for the first time. The team gave granular operational metrics across all five verticals and quantified capex and deleveraging milestones, while keeping corporate development options for Zigly and sensitive tenders confidential.

Specific or vague
Management provided detailed segment margin data per kg (base BOPP at Rs 29/kg, BOPET at Rs 12/kg, specialty at Rs 62/kg, semi-specialty at Rs 40/kg), breakdown of one-offs, and clear targets for debt reduction and capex.
Candour
Management openly acknowledged that consumer verticals will continue to incur losses over the next two years to build brand equity, and disclosed that recent inventory losses were Rs 7 crore.
The hard questions
Analysts probed into reconciling the BOPP spreads without one-offs vs Q1, the commercialization timeline of the Zigly transaction, and high freight/port congestion. Management directly addressed freight and spreads, but deferred on Zigly transaction specifics citing confidentiality and ongoing evaluations.

What analysts pressed on

  • Sustainability of elevated BOPP spreads given one-offs and raw material volatility.
  • Timeline and path to break-even for B2C consumer businesses (Zigly and Cosmo Consumer) amid aggressive marketing spend.
  • Clarity on the long-pending value-unlocking or fundraise transaction for Zigly.
  • Potential risk of further high-cost inventory write-downs following recent raw material price movements.

Answers that sidestepped

  • Aman Agarwal's inquiry regarding the concrete transaction or valuation unlock in Zigly was answered with general statements ('allow us to come back to you when we have something concrete').
  • Aman Kumar Sonthalia's question on currency note tender participation was deflected citing NDAs and confidentiality.

Numbers against the story

Management's narrative highlighted Q2 FY27 EBITDA of Rs 177 crore (+38% YoY) and net profit of Rs 99 crore (+111% YoY). However, reported figures show reported EBITDA at Rs 143.0 crore (10.3% margin) versus company-presented EBITDA of Rs 177 crore (12.8% margin), because the company included the non-recurring US customs duty write-back of Rs 24.8 crore and excluded other adjustments. Management candidly clarified that after netting the Rs 24.8 crore duty refund against Rs 7 crore inventory loss, normalized EBITDA was Rs 159 crore (+24% YoY growth). Furthermore, the 111% PAT surge was substantially aided by a Rs 14 crore one-off tax credit rather than core operating leverage.

Sources

Notes written by gemini-3.8-flash from the documents above on 15 November 2026. They summarise what the company said and can contain mistakes: check the source passage before relying on a point. Not investment advice.